Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase C and casein kinase substrate in neurons protein 3 (PACSIN3, also called syndapin III) is a cytoplasmic protein highly expressed in muscle tissue, where it is necessary for the biogenesis of caveolae—flask-shaped plasma membrane invaginations involved in membrane tension buffering and signaling[2][4][5]. PACSIN3 contains an F-BAR domain, which confers membrane-shaping ability, and an SH3 domain, mediating protein–protein interactions[1][3]. It localizes to the plasma membrane, particularly at transition zones between flat membrane and caveolar invaginations, where it helps structure and stabilize caveolae, especially those marked by caveolin-3 (CAV3) in muscle cells[2][4][5]. Its absence disrupts proper caveolae formation, compromising muscle cell integrity during mechanical stress, and appears linked to certain muscular diseases[2][4][5]. It is not classified as a therapeutic target (e.g., receptor, enzyme, transporter) and no approved drugs directly target it[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase C and casein kinase substrate in neurons protein 3 (PACSIN3).